CORC

在结果中检索

CORC

浏览/检索结果: 共18条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Successful treatment of a lung adenocarcinoma patient with a novel EGFR exon 20-ins mutation with afatinib A case report 期刊论文
MEDICINE, 2019, 卷号: 98, 期号: 1
作者:  Cai, Yangyang;  Wang, Xu;  Guo, Ye;  Sun, Chao;  Xu, Yinghui
收藏  |  浏览/下载：28/0  |  提交时间：2019/12/05
Heterogeneity Analyses of MSLCs-Especially in the EGFR Mutation-Positive Ones 会议论文
作者:  Xu, Y.;  Wang, X.;  Cai, Y.;  Guo, Y.;  Sun, C.
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study 期刊论文
THORACIC CANCER, 2018, 卷号: 9, 期号: 11
作者:  Cheng, Ying;  Wang, Yan;  Zhao, Jun;  Liu, Yunpeng;  Gao, Hongjun
收藏  |  浏览/下载：15/0  |  提交时间：2019/12/05
Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN) a randomised, open-label, phase 2 trial 期刊论文
LANCET RESPIRATORY MEDICINE, 2018, 卷号: 6, 期号: 11
作者:  Chen, Chun;  Yue, Dongsheng;  Xu, Shidong;  Wang, Qun;  Li, Xiaofei
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
[Study Progression on Non-small Cell Lung Cancer with EGFR Mutation Treated by Immune Checkpoint Inhibitors]. 期刊论文
Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2018, 卷号: 21, 期号: 8
作者:  Chen Naifei;  Bai Rilan;  Cui Jiuwei
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Gefitinib as third-line re-challenge treatment in advanced NSCLC patients with EGFR activating mutation who benefited from first-line gefitinib treatment followed by second-line chemotherapy 期刊论文
Journal of Clinical Oncology, 2017, 卷号: 35
作者:  Song Y., Wu Y.-L., Cao L., Chen J., Ma Z., Cui J., Ye X., Ding J.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study 期刊论文
ANNALS OF ONCOLOGY, 2017, 卷号: 28, 期号: 10
作者:  Liu, X. Q.;  Shi, Y. K.;  Wang, L.;  Han, B. H.;  Li, W.
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6 期刊论文
BRITISH JOURNAL OF CANCER, 2017, 卷号: 116, 期号: 2
作者:  Wu, Yi-Long;  Sequist, Lecia V.;  Hu, Cheng-Ping;  Feng, Jifeng;  Lu, Shun
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Efficacy and Safety of Erlotinib vs Vinorelbine/Cisplatin as Adjuvant Therapy for Stage IIIA EGFR Mutant NSCLC Patients 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 期号: 11
作者:  Yue, D.;  Xu, S.;  Wang, Q.;  Li, X.;  Shen, Y.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
First-line icotinib versus cisplatine/pemetrexed plus pemetrexed maintenance therapy in lung adenocarcinoma patients with EGFR mutation (CONVINCE) 会议论文
作者:  Shi, Y-K.;  Wang, L.;  Han, B.;  Li, W.;  Yu, P.
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace